Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Second Quarter 2026 Results
Second quarter 2026 results were reviewed by management during a live audio webcast with the financial community on July 30, 2026. The presentation was followed by a Q&A session.
Press Releases
Upcoming Events
9Sep
Kepler Cheuvreux Autumn Conference l Paris
Speaker : Thomas Grenier, Head of North America, Vaccines
Conferences
30Oct
Third quarter 2026 results
Third quarter 2026 results will be reviewed by management during a live audio webcast with the financial community on October 30, 2026. The presentation will be followed by a Q&A session.
12:30 - 13:30 CET (6:30am - 7:30am EDT)
Quarterly results
28Apr
Annual General Meeting 2027
The Sanofi General Meeting will be held on April 28, 2027.
Annual general meetings
Dividend (in dollars) per ADR (½ share)
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00